Alina Fomovska

发表

Salicylanilide inhibitors of Toxoplasma gondii.

C. Roberts, R. McLeod, W. Welsh, 2012, Journal of medicinal chemistry.

Synthesis, biological evaluation, and structure-activity relationships of N-benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), Trypanosomes, and Leishmania.

W. Witola, R. McLeod, A. Kozikowski, 2012, Journal of medicinal chemistry.

Modification of Triclosan Scaffold in Search of Improved Inhibitors for Enoyl‐Acyl Carrier Protein (ACP) Reductase in Toxoplasma gondii

D. Rice, S. Prigge, C. Roberts, 2013, ChemMedChem.

Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections

W. Witola, K. El Bissati, R. McLeod, 2012, Proceedings of the National Academy of Sciences.

Spiroindolone That Inhibits PfATPase4 Is a Potent, Cidal Inhibitor of Toxoplasma gondii Tachyzoites In Vitro and In Vivo

R. McLeod, S. Muench, Ying Zhou, 2013, Antimicrobial Agents and Chemotherapy.

Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.

Joel S. Freundlich, D. Rice, C. Fishwick, 2013, Biochemistry.

Novel N-Benzoyl-2-Hydroxybenzamide Disrupts Unique Parasite Secretory Pathway

D. Rice, S. Prigge, W. Witola, 2012, Antimicrobial Agents and Chemotherapy.

Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase.

D. Rice, S. Prigge, C. Roberts, 2013, Bioorganic & medicinal chemistry letters.

Modification of Triclosan Scaffold in Search of Improved Inhibitors for Enoyl‐Acyl Carrier Protein (ACP) Reductase in Toxoplasma gondii

D. Rice, S. Prigge, C. Roberts, 2013, ChemMedChem.